AMRN Amarin
- 0.455
- -0.005-1.06%
- 0.469
- +0.014+3.01%
Amarin News
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bolt Biotherapeutics (BOLT) and Amarin (AMRN)
Amarin's Stock Maintains Hold Rating Amidst Revenue Highs and Market Challenges
Amarin's Sell Rating Upheld Amid Revenue Concerns and Market Access Challenges
Amarin Corp Analyst Ratings
Amarin's Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growth
Amarin's Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansion
Analysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Amarin (AMRN) and Mereo Biopharma Group Plc (MREO)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF) and Amarin (AMRN)
Amarin Corp Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Humana (HUM), Ocular Therapeutix (OCUL) and Amarin (AMRN)
Jefferies Downgrades Amarin Corp to Hold, Lowers Price Target to $1
Amarin Corp Analyst Ratings
Goldman Sachs Maintains Sell on Amarin Corp, Lowers Price Target to $1
Amarin Corp Analyst Ratings
Northland Capital Markets Maintains Market Perform on Amarin Corp, Lowers Price Target to $1.25
Amarin Corp Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Amarin (AMRN) and Myriad Genetics (MYGN)
Analysts Offer Insights on Healthcare Companies: Amarin (AMRN), Ascendis Pharma (ASND) and MoonLake Immunotherapeutics (MLTX)
SVB Securities Sticks to Their Hold Rating for Amarin (AMRN)
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fulcrum Therapeutics (FULC) and Amarin (AMRN)
No Data